Endoscopic Submucosal Dissection Market by Product, Indication, End User

Description

List of Tables

The Global Endoscopic Submucosal Dissection Market is forecasted to grow significantly, with a projected USD 320.68 million in 2023 at a CAGR of 6.79% and expected to reach a staggering USD 513.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Endoscopic Submucosal Dissection Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Endoscopic Submucosal Dissection Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Cap & Hood, Forceps & Clips, Gastroscopes & Colonoscopes, and Knives. The Knives is further studied across Dual, Flex, Hook, Insulation-tipped, Needle, and Triangle-tipped. The Gastroscopes & Colonoscopes commanded largest market share of 32.48% in 2022, followed by Knives.

Based on Indication, market is studied across Colon & Rectum Cancer, Esophageal Cancer, and Stomach Cancer. The Colon & Rectum Cancer commanded largest market share of 39.47% in 2022, followed by Stomach Cancer.

Based on End User, market is studied across Ambulatory Surgical Centres, Hospitals, and Specialty Clinics. The Hospitals commanded largest market share of 79.07% in 2022, followed by Specialty Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.01% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Endoscopic Submucosal Dissection Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Endoscopic Submucosal Dissection Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Endoscopic Submucosal Dissection Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Endoscopic Submucosal Dissection Market?

4. What is the competitive strategic window for opportunities in the Global Endoscopic Submucosal Dissection Market?

5. What are the technology trends and regulatory frameworks in the Global Endoscopic Submucosal Dissection Market?

6. What is the market share of the leading vendors in the Global Endoscopic Submucosal Dissection Market?

7. What modes and strategic moves are considered suitable for entering the Global Endoscopic Submucosal Dissection Market?

Product Code: MRR-F611BFBC6423

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Endoscopic Submucosal Dissection Market, by Product, 2022 vs 2030
4.3. Endoscopic Submucosal Dissection Market, by Indication, 2022 vs 2030
4.4. Endoscopic Submucosal Dissection Market, by End User, 2022 vs 2030
4.5. Endoscopic Submucosal Dissection Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing geriatric population coupled with rising incidences of cancer
  - 5.1.1.2. Favorable reimbursement policies for endoscopic procedures
  - 5.1.1.3. Growing adoption of minimally invasive surgeries across the globe
- 5.1.2. Restraints
  - 5.1.2.1. High capital and maintenance cost of endoscopic submucosal dissection procedures
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing number of approvals for endoscopic submucosal dissection techniques
  - 5.1.3.2. Technological advancements in endoscopic submucosal dissection techniques and devices
- 5.1.4. Challenges
  - 5.1.4.1. Side effects associated with postoperative infection of endoscopic submucosal dissection procedures
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Endoscopic Submucosal Dissection Market, by Product

6.1. Introduction
6.2. Cap & Hood
6.3. Forceps & Clips
6.4. Gastroscopes & Colonoscopes
6.5. Knives
- 6.5.1. Dual
- 6.5.2. Flex
- 6.5.3. Hook
- 6.5.4. Insulation-tipped
- 6.5.5. Needle
- 6.5.6. Triangle-tipped

7. Endoscopic Submucosal Dissection Market, by Indication

7.1. Introduction
7.2. Colon & Rectum Cancer
7.3. Esophageal Cancer
7.4. Stomach Cancer

8. Endoscopic Submucosal Dissection Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centres
8.3. Hospitals
8.4. Specialty Clinics

9. Americas Endoscopic Submucosal Dissection Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Endoscopic Submucosal Dissection Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Submucosal Dissection Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Agreement, Collaboration, & Partnership
  - 12.3.1.1. Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
- 12.3.2. New Product Launch & Enhancement
  - 12.3.2.1. Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field
  - 12.3.2.2. Fujifilm expands endoscopy solutions for gastrointestinal applications
  - 12.3.2.3. Medtronic launches AI-driven endoscopy module to detect, treat colorectal cancer
- 12.3.3. Investment & Funding
  - 12.3.3.1. Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
- 12.3.4. Award, Recognition, & Expansion
  - 12.3.4.1. Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc.
  - 12.3.4.2. Lumendi Receives 510(k) Clearance for Two Endoscopy Devices
  - 12.3.4.3. Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

1. Advanced Endoscopy Devices, Inc.

2. Ambu A/S

3. Angelus Medical and Optical

4. Anrei Medical

5. Aohua Endoscopy Co., Ltd.

6. Aspen Surgical

7. Avante Medical Surgical

8. Beijing ZKSK Technology Co., Ltd.

9. Boston Scientific Corporation

10. ConMed Corporation

11. Cook Group Incorporated

12. Creo Medical

13. Duomed Group

14. EndoMed Systems GmbH

15. Endoss GmbH

16. Erbe Elektromedizin GmbH

17. Etsy, Inc.

18. Flexicare Medical Ltd.

19. Fujifilm Holdings Corporation

20. Guangzhou Happycare Electronics Co., Ltd.

21. Hangzhou AGS MedTech Co., Ltd.

22. HMB Endoscopy Products

23. Hoya Corporation

24. Huger Medical Instrument Co., Ltd.

25. Interscope, Inc.

26. Jiangsu Maslech Medical Technology Co., Ltd.

27. Jiangsu Vedkang Medical Science and Technology Co., Ltd.

28. Karl Storz SE & Co. KG

29. Lenox Instrument Company

30. Leo Medical Co. Ltd.

31. Medi-Globe GmbH by DCC Healthcare

32. MedTec Applications, Inc.

33. Medtronic PLC

34. Micro-Tech Endoscopy

35. MicroAire Surgical Instruments, LLC

36. Mizuho America, Inc.

37. MTW-Endoskopie W. Haag KG

38. Olympus Corporation

39. Optim LLC

40. Ovesco Endoscope AG

41. Port Macquarie Gastroenterology

42. Pride Medical Instruments Technology Jiangsu Co., Ltd.

43. Richard Wolf Industrial

44. SonoScape Medical Corp.

45. Steris Corporation

46. Sumitomo Bakelite Co., Ltd.

47. Taewoong Medical

48. The Surgical Company

49. Vector Medical

50. Zeon Medical Inc.